A 52-week, open label, parallel group, multicentre, phase III, randomised controlled trial to compare the efficacy and safety of Budesonide/formoterol turbuhaler taken as required for relief of symptoms and Budesonide turbuhaler as maintenance and terbutaline turbuhaler as required for relief of symptoms of asthma in adults
Latest Information Update: 08 Oct 2020
At a glance
- Drugs Budesonide (Primary) ; Budesonide/formoterol (Primary) ; Terbutaline (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms PRACTICAL
- 12 Aug 2020 Results of a subgroup analysis assessing the nfluence of ethnicity on the efficacy of as-needed budesonide-formoterol vs maintenance budesonide and as-needed terbutaline published in the New Zealand Medical Journal
- 27 Jul 2020 Results of subgroup analysis from the PRACTICAL study(n=407) detrming Discrete choice experiments in asthma patients, published in the Thorax